Menu Search
Equities

H.U. Group Holdings Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
MRCHF:PKL

H.U. Group Holdings Inc

Actions
  • Price (USD)20.99
  • Today's Change0.000 / 0.00%
  • Shares traded25.00
  • 1 Year change--
  • Beta0.3369
Data delayed at least 15 minutes, as of Feb 12 2026 20:42 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

H.U. Group Holdings Inc, formerly Miraca Holdings Inc is a Japan-based holding company engaged in manufacture and sale of clinical test drugs, entrusted clinical examination and sterilization related business. The Company operates in four business segments. The Outsourced Clinical Testing segment accepts special tests from medical institutions. The Clinical Laboratory Medicine segment manufactures and sells clinical laboratory medicines and sells them to medical institutions and contract clinical laboratory companies. The Sterilization segment mainly entrusts the sterilization of medical equipment used for medical treatment in hospitals of large-scale hospitals and the related operations. The New Development & Others segment is involved in the homecare & welfare equipment business, self-medication & health insurance business, food & environment & cosmetics inspection business.

  • Revenue in JPY (TTM)247.71bn
  • Net income in JPY5.57bn
  • Incorporated1950
  • Employees5.44k
  • Location
    H.U. Group Holdings IncAkasaka Intercity AIR, 1-8-1, AkasakaMINATO-KU 107-0052JapanJPN
  • Phone+81 359093335
  • Fax+81 359093336
  • Websitehttps://www.hugp.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.